ENTRY       D10669                      Drug
NAME        Sotagliflozin (USAN/INN);
            Inpefa (TN)
PRODUCT     INPEFA (Lexicon Pharmaceuticals)
FORMULA     C21H25ClO5S
EXACT_MASS  424.1111
MOL_WEIGHT  424.9382
CLASS       Antidiabetic agent
             DG02044  Hypoglycemic agent
              DG01794  SGLT2 inhibitor
            Metabolizing enzyme substrate
             DG01633  CYP3A/CYP3A4 substrate
              DG02913  CYP3A4 substrate
             DG02924  UGT substrate
              DG03188  UGT1A9 substrate
REMARK      ATC code: A10BK06
            Product: D10669<US>
EFFICACY    SGLT inhibitor
COMMENT     Phlorizin derivative
            Treatment of heart failure
TARGET      SLC5A1 (SGLT1) [HSA:6523] [KO:K14158]
            SLC5A2 (SGLT2) [HSA:6524] [KO:K14382]
  PATHWAY   hsa04973(6523)  Carbohydrate digestion and absorption
            hsa04976(6523)  Bile secretion
            hsa04978(6523)  Mineral absorption
METABOLISM  Enzyme: UGT1A9 [HSA:54600]; CYP3A4 [HSA:1576]
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             A ALIMENTARY TRACT AND METABOLISM
              A10 DRUGS USED IN DIABETES
               A10B BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
                A10BK Sodium-glucose co-transporter 2 (SGLT2) inhibitors
                 A10BK06 Sotagliflozin
                  D10669  Sotagliflozin (USAN/INN) &lt;US&gt;
            USP drug classification [BR:br08302]
             Cardiovascular Agents
              Sodium-Glucose Co-Transporter 2 Inhibitors (SGLT2i)
               Sotagliflozin
                D10669  Sotagliflozin (USAN/INN)
            Drug groups [BR:br08330]
             Antidiabetic agent
              DG02044  Hypoglycemic agent
               DG01794  SGLT2 inhibitor
                D10669  Sotagliflozin
             Metabolizing enzyme substrate
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                D10669  Sotagliflozin
              DG02924  UGT substrate
               DG03188  UGT1A9 substrate
                D10669  Sotagliflozin
            Target-based classification of drugs [BR:br08310]
             Transporters
              Solute carrier family
               SLC5
                SLC5A1 (SGLT1)
                 D10669  Sotagliflozin (USAN/INN) &lt;US&gt;
                SLC5A2 (SGLT2)
                 D10669  Sotagliflozin (USAN/INN) &lt;US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D10669
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D10669
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D10669
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D10669
DBLINKS     CAS: 1018899-04-1
            PubChem: 254741630
            PDB-CCD: LFL
ATOM        28
            1   C1y C    14.4200  -16.8000
            2   O2x O    14.4200  -15.4000
            3   C1y C    13.1600  -14.7000
            4   C1y C    11.9700  -15.4000
            5   C1y C    11.9700  -16.8000
            6   C1y C    13.1600  -17.5000
            7   C8x C    21.6300  -19.7400
            8   C8y C    22.8200  -19.0400
            9   C8x C    22.8200  -17.6400
            10  C8x C    21.7000  -16.9400
            11  C8y C    20.4400  -17.6400
            12  C8x C    20.4400  -18.9700
            13  C8y C    18.0600  -18.9700
            14  C8y C    18.0600  -17.5700
            15  C8x C    16.8700  -16.8000
            16  C8y C    15.6100  -17.5000
            17  C8x C    15.6100  -18.9000
            18  C8x C    16.8000  -19.6700
            19  C1b C    19.2500  -16.8700
            20  O2a O    24.0800  -19.7400
            21  C1b C    25.2700  -19.0400
            22  C1a C    26.4600  -19.7400
            23  X   Cl   19.3200  -19.6700
            24  S2a S    13.1600  -13.3000
            25  C1a C    14.4200  -12.6000
            26  O1a O    10.7800  -14.7000
            27  O1a O    10.7800  -17.5000
            28  O1a O    13.1600  -18.9000
BOND        30
            1     1   2 1
            2     2   3 1
            3     3   4 1
            4     4   5 1
            5     5   6 1
            6     1   6 1
            7     7   8 2
            8     8   9 1
            9     9  10 2
            10   10  11 1
            11   11  12 2
            12    7  12 1
            13   13  14 2
            14   14  15 1
            15   15  16 2
            16   16  17 1
            17   17  18 2
            18   13  18 1
            19   14  19 1
            20   11  19 1
            21    8  20 1
            22   20  21 1
            23   21  22 1
            24   13  23 1
            25    1  16 1 #Up
            26    3  24 1 #Up
            27   24  25 1
            28    4  26 1 #Down
            29    5  27 1 #Up
            30    6  28 1 #Down
///
